F1D8N1 (F1D8N1_HUMAN) Homo sapiens (Human)
Liver X nuclear receptor alpha variant 1 UniProtKBInterProInteractive Modelling
447 aa; Sequence (Fasta) ;
4 identical sequences: Homo sapiens: Q13133; Pan troglodytes: A0A6D2XX46, K7AUZ1; Pan paniscus: A0A2R9BV37
Available Structures
7 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 32b |
Heteromer Q13133; Q15788; | 100.0 | 2×4KQ; | |||
Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4 |
Heteromer Q13133; Q15788; | 100.0 | 2×4KM; | |||
Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease |
Heteromer Q13133; Q15788; | 100.0 | 2×668; 2×SO4; | |||
X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha |
Heteromer Q13133; Q15788; | 100.0 | 2×SO4; 2×O90; | |||
X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha |
Heteromer Q13133; Q15788; | 100.0 | 2×O40; 2×SO4; | |||
X-ray structure of GW3965 synthetic agonist bound to the LXR-alpha |
Heteromer Q13133; Q15788; | 100.0 | 2×965; 2×SO4; | |||
Crystal structure of the LXRalfa-RXRbeta LBD heterodimer |
Heteromer P28702; Q13133; Q15596; | 100.0 | 1×MEI; 1×444; | |||
12 SWISS-MODEL models
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4nqa.1.B | monomer | 0.74 | 2×ZN; | 73.70 | ||
4nqa.2.B | monomer | 0.74 | 2×ZN; 1×965; | 73.70 | ||
5uan.1.B | monomer | 0.65 | 1×ZN; | 34.23 | ||
7wnh.4.A | monomer | 0.62 | 1×ZN; | 29.43 | ||
7wnh.2.A | monomer | 0.61 | 2×ZN; | 29.43 | ||
3dzy.1.B | monomer | 0.61 | 1×ZN; | 28.65 | ||
4iqr.2.B | monomer | 0.57 | 2×ZN; | 30.72 | ||
4iqr.2.A | monomer | 0.57 | 2×ZN; | 30.72 | ||
7prw.1.B | monomer | 0.57 | 2×ZN; | 24.25 | ||
3dzy.1.A | monomer | 0.52 | 2×ZN; | 31.09 | ||
5uan.1.A | monomer | 0.52 | 1×ZN; | 31.49 | ||
4nqa.2.A | monomer | 0.51 | 1×ZN; | 31.49 | ||